Filter Results:
(689)
Show Results For
- All HBS Web
(689)
- News (194)
- Research (389)
- Multimedia (2)
- Faculty Publications (177)
Show Results For
- All HBS Web
(689)
- News (194)
- Research (389)
- Multimedia (2)
- Faculty Publications (177)
- 15 Aug 2006
- First Look
First Look: August 15, 2006
carburetors. Download working paper: http://www.hbs.edu/research/pdf/07-009.pdf Cases & Course MaterialsInnovating in Health Care—Framework Harvard Business School Note 306-042 Contains the framework for the second-year Innovating... View Details
Keywords: Sean Silverthorne
- Article
Defining the Value Framework for Prostate Brachytherapy Using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing
By: N.G. Thaker, T.J. Pugh, U. Mahmood, S. Choi, T.E. Spinks, N.E. Martin, T.T. Sio, R.J. Kudchadker, R. S. Kaplan, D.A. Kuban, D.A. Swanson, P.F. Orio, M.J. Zelefsky, B.W. Cox, L. Potters, T.A. Buchholz, T.W. Feeley and S.J. Frank
PURPOSE:
Value, defined as outcomes over costs, has been proposed as a measure to evaluate prostate cancer (PCa) treatments. We analyzed standardized outcomes and time-driven activity-based costing (TDABC) for prostate brachytherapy (PBT) to define a value... View Details
Thaker, N.G., T.J. Pugh, U. Mahmood, S. Choi, T.E. Spinks, N.E. Martin, T.T. Sio, R.J. Kudchadker, R. S. Kaplan, D.A. Kuban, D.A. Swanson, P.F. Orio, M.J. Zelefsky, B.W. Cox, L. Potters, T.A. Buchholz, T.W. Feeley, and S.J. Frank. "Defining the Value Framework for Prostate Brachytherapy Using Patient-Centered Outcome Metrics and Time-Driven Activity-Based Costing." Brachytherapy 15, no. 3 (May 2016): 274–282.
- June 2023
- Case
Verve Therapeutics: Taking DNA Editing to Heart
By: Shikhar Ghosh and Shweta Bagai
Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details
Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry
Ghosh, Shikhar, and Shweta Bagai. "Verve Therapeutics: Taking DNA Editing to Heart." Harvard Business School Case 823-113, June 2023.
- 29 Jun 2013
- News
Hospital operators and Obamacare: Prescription for change
- 03 Jun 2020
- Research & Ideas
Who Guarantees Your Workplace Is Safe for Return?
Here are key requirements to ask of any service provider offering to certify your work setting as a healthy building. These best practices apply for employers, employees, and customers alike. Our research over many decades in public View Details
- July–September 2018
- Article
Memory Bias in Observer-Performance Literature
By: Tamara M. Haygood, Samantha N. Smith and Jia Sun
The objective of our study was to determine how authors of published observer–performance experiments dealt with memory bias in study design. We searched American Journal of Roentgenology online and Radiology using “observer study” and “observer performance.” We... View Details
Haygood, Tamara M., Samantha N. Smith, and Jia Sun. "Memory Bias in Observer-Performance Literature." Art. 031412. Journal of Medical Imaging 5, no. 3 (July–September 2018).
Clayton S. Rose
Clayton Rose is Baker Foundation Professor of Management Practice and teaches the course Accountability in the Advanced Management Program. His case writing is focused on the how leaders consider the... View Details
Keywords: financial services
- February 2006 (Revised August 2006)
- Case
deCODE Genetics: Hunting for Genes to Develop Drugs
By: Debora L. Spar
In 1996, Kari Stefansson launched a new kind of biotechnology company and a whole new way of attacking diseases. Based in Iceland, his firm, deCODE Genetics, plans to identify the individual genetic markers that lead to society's most prevalent diseases. To do so, it... View Details
Keywords: Information; Innovation Strategy; Genetics; Ethics; Health Disorders; Biotechnology Industry; Iceland
Spar, Debora L., and Chris Bebenek. "deCODE Genetics: Hunting for Genes to Develop Drugs." Harvard Business School Case 706-040, February 2006. (Revised August 2006.)
- 02 Aug 2021
- Blog Post
Uncovering the Virtual Advantage at Humana
In March 2020, first-year MBA students and their prospective internship employers faced an unprecedented challenge: What to do about summer internships during a global health pandemic? Some students seeking internships saw potential leads... View Details
- 02 Apr 2015
- Research & Ideas
Digital Summit Explores the New Economy
difficult to have innovation without data—which is one reason why the health care industry in the United States is too expensive. One remedy: Make the patient the customer. who Has The Power In The Music Industry? With inexpensive View Details
- Article
Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii
By: Michel Anteby, Filiz Garip, Paul V. Martorana and Scott Lozanoff
Background: Human cadavers are crucial to numerous aspects of health care, including initial and continuing training of medical doctors and advancement of medical research. Concerns have periodically been raised about the limited number of whole body... View Details
Keywords: Decisions; Health Care and Treatment; Personal Characteristics; Philanthropy and Charitable Giving; Health Industry; Hawaii
Anteby, Michel, Filiz Garip, Paul V. Martorana, and Scott Lozanoff. "Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii." PLoS ONE 7, no. 8 (August 2012). (e42673. doi:10.1371/journal.pone.0042673.)
- 10 Aug 2020
- Blog Post
HBS Summer Fellows Focus on Racial Equity and Justice
students engaging in this critical work. This summer, HBS is supporting a record 161 Social Enterprise Summer Fellows, with many organizations and projects focused on racial equity and justice. The Social Enterprise Initiative connected... View Details
- 30 Oct 2012
- First Look
First Look: October 30
School Case 712-496 In 2006, surgeon Ara Darzi identified several key areas, including acute stroke care, for improving health care across London. In response to his seminal call to action, stroke care was reorganized around eight... View Details
Keywords: Sean Silverthorne
- June 2015 (Revised August 2016)
- Case
Qualcomm Inc., 2009-2015
By: David B. Yoffie
In the years after 2009, Qualcomm navigated the wireless industry's transition from 3G to 4G, retaining its technological leadership and experiencing dramatic growth in revenue and profit. In March 2014, Qualcomm appointed a new CEO, Steve Mollenkopf, who had to... View Details
Keywords: Communication Technologies; Technology; Wireless Technologies; Mobile and Wireless Technology; Strategy; Communication Technology; Competitive Strategy; Change Management; Electronics Industry; Electronics Industry; California
Yoffie, David B. "Qualcomm Inc., 2009-2015." Harvard Business School Case 715-467, June 2015. (Revised August 2016.)
- October 2007
- Case
Colgate Max Fresh: Global Brand Roll-Out
By: John A. Quelch
In February 2005, Nigel Burton, in his third year as president of global oral care at Colgate-Palmolive Company (CP), had every reason to feel optimistic. Worldwide market shares were strong and Colgate Max Fresh (CMF), a new toothpaste that had helped drive Colgate to... View Details
Keywords: Marketing Strategy; Product Launch; Global Strategy; Brands and Branding; Health Industry; Health Industry; China; Mexico
Quelch, John A., and Jacquie Labatt-Randle. "Colgate Max Fresh: Global Brand Roll-Out." Harvard Business School Case 508-009, October 2007.
Henry W. McGee
Henry McGee joined the HBS faculty in 2013 after retiring as President of HBO Home Entertainment, the digital and DVD program distribution division of Home Box Office, the pioneering premium television company. A member of the Entrepreneurial Management Unit,... View Details
- April 2024
- Article
A Machine Learning Algorithm Predicting Risk of Dilating VUR among Infants with Hydronephrosis Using UTD Classification
By: Hsin-Hsiao Scott Wang, Michael Lingzhi Li, Dylan Cahill, John Panagides, Tanya Logvinenko, Jeanne Chow and Caleb Nelson
Backgrounds: Urinary Tract Dilation (UTD) classification has been designed to be a more objective grading system to evaluate antenatal and post-natal UTD. Due to unclear association between UTD classifications to specific anomalies such as vesico-ureteral reflux (VUR),... View Details
Wang, Hsin-Hsiao Scott, Michael Lingzhi Li, Dylan Cahill, John Panagides, Tanya Logvinenko, Jeanne Chow, and Caleb Nelson. "A Machine Learning Algorithm Predicting Risk of Dilating VUR among Infants with Hydronephrosis Using UTD Classification." Journal of Pediatric Urology 20, no. 2 (April 2024): 271–278.
- July 2023
- Case
Moderna: Everything, Everywhere, All at Once
By: Satish Tadikonda, Shikhar Ghosh and William Marks
Coming out of the COVID-19 pandemic, Moderna was riding the successes of developing a vaccine in record time and helping stem the tide of the crisis. However, the company had grown at an incredible rate, more than doubled its number of employees, and had to put on hold... View Details
Keywords: Health Pandemics; Selection and Staffing; Growth Management; Management Succession; Retirement; Technological Innovation; Corporate Strategy; Biotechnology Industry
Tadikonda, Satish, Shikhar Ghosh, and William Marks. "Moderna: Everything, Everywhere, All at Once." Harvard Business School Case 824-021, July 2023.
- 24 Oct 2006
- First Look
First Look: October 24, 2006
improving forecasts in corporate settings. We examine the implementation of a supply chain planning process at a consumer electronics company, concentrating on the consensus forecasting approach around which the process revolves. Our... View Details
Keywords: Sean Silverthorne